Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Presymptomatic Awareness of Germline Pathogenic BRCA Variants and Associated Outcomes in Women With Breast Cancer.

JAMA oncology - 1 Sept 2020

Hadar Tal, Mor Pnina, Amit Gefen, Lieberman Sari, Gekhtman David, Rabinovitch Rachel, Levy-Lahad Ephrat

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Variation

Share to Germ-Line Mutation

Share to Kaplan-Meier Estimate

Source

Open in PubMed Open full text

Identifiers

PMID: 32644100
DOI: 10.1001/jamaoncol.2020.2059
PMCID: PMC7349080

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Presymptomatic Awareness of Germline Pathogenic BRCA Variants and Associated Outcomes in Women With Breast Cancer.PMID 32644100Read ↗

Germline Pathogenic Variants in BRCA1 and BRCA2: Malignancies Beyond Female Breast and Ovarian Cancers.Semantic proximity Read ↗

BRCA-associated cancer risk: molecular biology and clinical practice.Semantic proximity Read ↗

Emerging cancer risks in BRCA2 pathogenic germline variant carriers.Semantic proximity Read ↗

Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status.Semantic proximity Read ↗

Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics.Semantic proximity Read ↗

Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline VariantsSemantic proximity Read ↗

[Germline mutations and breast cancer risk].Semantic proximity Read ↗

Evidence Grows for Universal Germline Genetic Testing for Patients with Breast Cancer.Semantic proximity Read ↗

Awareness and Candidacy for Endocrine Prevention and Risk Reducing Mastectomy in Unaffected High-Risk Women Referred for Breast Cancer Risk Assessment.Semantic proximity Read ↗

Two decades after BRCA: setting paradigms in personalized cancer care and prevention.Semantic proximity Read ↗

Breast cancer in young women: do BRCA1 or BRCA2 mutations matter?Semantic proximity Read ↗

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.